Clinical features and treatment of ruptured pulmonary hydatid cyst in children

Tunç Özdemir1, Ali Sayan1, Belce Candan1

  • 1Department of Pediatric Surgery, University of Medical Sciences, Tepecik Training and Research Hospital, İzmir.

Insights

Rupture of pulmonary hydatid cysts (HC) is a serious complication. Simple cystotomy is an effective treatment, avoiding complications like air leaks.

Area of Science:

  • Pediatric Surgery
  • Infectious Diseases
  • Thoracic Surgery

Background:

  • Pulmonary hydatid cyst (HC) rupture is a major clinical concern.
  • Understanding clinical features and treatment is crucial for managing ruptured HC.

Purpose of the Study:

  • To evaluate clinical features of ruptured pulmonary HC in children.
  • To assess the effectiveness of surgical treatment for ruptured pulmonary HC.

Main Methods:

  • Retrospective evaluation of medical records of pediatric patients who underwent surgery for pulmonary HC between 1999 and 2017.
  • Analysis of clinical data including demographics, symptoms, diagnosis, and treatment outcomes for 147 patients with ruptured HC.

Main Results:

  • The most common symptoms in ruptured HC were cough with mucopurulent sputum, hydropthysis, and dyspnea.
  • Diagnosis was confirmed using chest X-ray and CT scans.
  • Simple cystotomy via posterolateral thoracotomy was the primary treatment; lung resection was reserved for severe destruction.

Conclusions:

  • Rupture of pulmonary HC is a common and feared complication, requiring emergent management.
  • Simple cystotomy with removal of laminated membranes is the treatment of choice.
  • Proper closure of bronchial openings is essential to prevent air leaks; capitonage is not necessary.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
705
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.8K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
462
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
418
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
335